DK1599490T3 - Fremgangsmode til fremstilling af antikonvulsive derivater af topiramat - Google Patents

Fremgangsmode til fremstilling af antikonvulsive derivater af topiramat

Info

Publication number: DK1599490T3
Authority: DK; Denmark
Prior art keywords: topiramate; preparation; anticonvulsant derivatives; anticonvulsant; derivatives
Prior art date: 2003-03-04

Application number

DK04716438T

Other languages

Danish (da)

English (en)

Inventor

Joachim Ernst Berkner

Scott Duncan

John Mills

Original Assignee

Ortho Mcneil Janssen Pharm

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-03-04

Filing date

2004-03-02

Publication date

2009-04-27

2004-03-02 Application filed by Ortho Mcneil Janssen Pharm filed Critical Ortho Mcneil Janssen Pharm

2009-04-27 Application granted granted Critical

2009-04-27 Publication of DK1599490T3 publication Critical patent/DK1599490T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C307/00—Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C307/02—Monoamides of sulfuric acids or esters thereof, e.g. sulfamic acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
- C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
- C07H9/04—Cyclic acetals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/12—Antiepileptics; Anticonvulsants for grand-mal
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C307/00—Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C307/04—Diamides of sulfuric acids

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Neurosurgery (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biomedical Technology (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Pain & Pain Management (AREA)
Neurology (AREA)
Veterinary Medicine (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Pyridine Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Saccharide Compounds (AREA)

DK04716438T 2003-03-04 2004-03-02 Fremgangsmode til fremstilling af antikonvulsive derivater af topiramat DK1599490T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US45186303P	2003-03-04	2003-03-04
PCT/US2004/006263 WO2004078769A1 (en)	2003-03-04	2004-03-02	Process for the preparation of anticonvulsant derivatives of topiramate

Publications (1)

Publication Number	Publication Date
DK1599490T3 true DK1599490T3 (da)	2009-04-27

Family

ID=32962650

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK04716438T DK1599490T3 (da)	2003-03-04	2004-03-02	Fremgangsmode til fremstilling af antikonvulsive derivater af topiramat

Country Status (27)

Country	Link
US (1)	US7157589B2 (es)
EP (1)	EP1599490B8 (es)
JP (1)	JP4725976B2 (es)
KR (1)	KR20050119111A (es)
CN (1)	CN100376591C (es)
AR (1)	AR043466A1 (es)
AT (1)	ATE421521T1 (es)
AU (1)	AU2004217974A1 (es)
BR (1)	BRPI0407967A (es)
CA (1)	CA2517964A1 (es)
CL (1)	CL2004000438A1 (es)
DE (1)	DE602004019191D1 (es)
DK (1)	DK1599490T3 (es)
ES (1)	ES2254047T3 (es)
HK (1)	HK1088336A1 (es)
HR (1)	HRP20050756A2 (es)
MX (1)	MXPA05009384A (es)
MY (1)	MY139235A (es)
NO (1)	NO20054538L (es)
NZ (1)	NZ541811A (es)
PT (1)	PT1599490E (es)
RU (1)	RU2333216C2 (es)
SI (1)	SI1599490T1 (es)
TW (1)	TW200504089A (es)
UA (1)	UA81657C2 (es)
WO (1)	WO2004078769A1 (es)
ZA (1)	ZA200507995B (es)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7638291B2 (en) *	2004-10-25	2009-12-29	Seradyn, Inc.	Immunoassays for topiramate
US20060088886A1 (en) *	2004-10-25	2006-04-27	Anlong Ouyang	Topiramate analogs
WO2007099388A1 (en) *	2006-03-01	2007-09-07	Glade Organics Private Limited	An improved process for the manufacture of topiramate
WO2008010231A2 (en) *	2006-05-26	2008-01-24	Alembic Limited	A process for the purification of topiramate
US20090076128A1 (en) *	2007-09-15	2009-03-19	Protia Llc	Deuterium-enriched topiramate
US9303038B2 (en)	2011-09-06	2016-04-05	Cellix Bio Private Limited	Compositions and methods for the treatment of epilepsy and neurological diseases
AU2013257742A1 (en)	2012-05-07	2014-11-27	Cellixbio Private Limited	Compositions and methods for treatment of neuromuscular disorders and neurodegenerative disorders
WO2013167985A1 (en)	2012-05-07	2013-11-14	Mahesh Kandula	Compositions and methods for the treatment of neurological disorders
WO2013167990A1 (en)	2012-05-07	2013-11-14	Mahesh Kandula	Compositions and methods for the treatment of depression
WO2013168025A1 (en)	2012-05-08	2013-11-14	Mahesh Kandula	Compositions and methods for treatment of blood clotting disorders
US9403826B2 (en)	2012-05-08	2016-08-02	Cellix Bio Private Limited	Compositions and methods for the treatment of inflammatory disorders
US9434704B2 (en)	2012-05-08	2016-09-06	Cellix Bio Private Limited	Compositions and methods for the treatment of neurological degenerative disorders
US9266823B2 (en)	2012-05-08	2016-02-23	Cellix Bio Private Limited	Compositions and methods for the treatment of parkinson's disease
WO2013167991A1 (en)	2012-05-08	2013-11-14	Mahesh Kandula	Compositions and methods for the treatment of metabolic disorders
WO2013168000A1 (en)	2012-05-10	2013-11-14	Mahesh Kandula	Compositions and methods for the treatment of severe pain
US9499527B2 (en)	2012-05-10	2016-11-22	Cellix Bio Private Limited	Compositions and methods for the treatment of familial amyloid polyneuropathy
US9315461B2 (en)	2012-05-10	2016-04-19	Cellix Bio Private Limited	Compositions and methods for the treatment of neurologic diseases
US9403857B2 (en)	2012-05-10	2016-08-02	Cellix Bio Private Limited	Compositions and methods for the treatment of metabolic syndrome
WO2013168015A1 (en)	2012-05-10	2013-11-14	Mahesh Kandula	Compositions and methods for the treatment of asthma and allergy
US9321775B2 (en)	2012-05-10	2016-04-26	Cellix Bio Private Limited	Compositions and methods for the treatment of moderate to severe pain
US9273061B2 (en)	2012-05-10	2016-03-01	Cellix Bio Private Limited	Compositions and methods for the treatment of chronic pain
WO2013167997A2 (en)	2012-05-10	2013-11-14	Mahesh Kandula	Compositions and methods for the treatment of metabolic syndrome
WO2013168005A2 (en)	2012-05-10	2013-11-14	Mahesh Kandula	Compositions and methods for the treatment of restless leg syndrome and fibromyalgia
US9233161B2 (en)	2012-05-10	2016-01-12	Cellix Bio Private Limited	Compositions and methods for the treatment of neurological conditions
US9346742B2 (en)	2012-05-10	2016-05-24	Cellix Bio Private Limited	Compositions and methods for the treatment of fibromyalgia pain
WO2013168012A1 (en)	2012-05-10	2013-11-14	Mahesh Kandula	Compositions and methods for the treatment of respiratory disorders
US9499526B2 (en)	2012-05-10	2016-11-22	Cellix Bio Private Limited	Compositions and methods for the treatment of neurologic diseases
US9492409B2 (en)	2012-05-23	2016-11-15	Cellix Bio Private Limited	Compositions and methods for the treatment of local pain
WO2013175377A2 (en)	2012-05-23	2013-11-28	Mahesh Kandula	Compositions and methods for the treatment of mucositis
CN104603097A (zh)	2012-05-23	2015-05-06	塞利克斯比奥私人有限公司	用于治疗多发性硬化症的组合物和方法
US9227974B2 (en)	2012-05-23	2016-01-05	Cellex Bio Private Limited	Compositions and methods for the treatment of respiratory disorders
SG11201407319YA (en)	2012-05-23	2014-12-30	Cellix Bio Private Ltd	Compositions and methods for treatment of inflammatory bowel disease
WO2013175344A2 (en)	2012-05-23	2013-11-28	Mahesh Kandula	Compositions and methods for the treatment of periodontitis and rheumatoid arthritis
US9108942B1 (en)	2014-11-05	2015-08-18	Mahesh Kandula	Compositions and methods for the treatment of moderate to severe pain
US9187427B2 (en)	2012-08-03	2015-11-17	Cellix Bio Private Limited	N-substituted nicotinamide compounds and compositions for the treatment migraine and neurologic diseases
WO2014037833A2 (en)	2012-09-06	2014-03-13	Mahesh Kandula	Compositions and methods for the treatment inflammation and lipid disorders
CN104364231A (zh)	2012-09-08	2015-02-18	塞利克斯比奥私人有限公司	用于治疗炎症和脂质异常的组合物和方法
US8652527B1 (en)	2013-03-13	2014-02-18	Upsher-Smith Laboratories, Inc	Extended-release topiramate capsules
US9101545B2 (en)	2013-03-15	2015-08-11	Upsher-Smith Laboratories, Inc.	Extended-release topiramate capsules
US9333187B1 (en)	2013-05-15	2016-05-10	Cellix Bio Private Limited	Compositions and methods for the treatment of inflammatory bowel disease
AU2014276346A1 (en)	2013-06-04	2015-12-24	Cellixbio Private Limited	Compositions and methods for the treatment of diabetes and pre-diabetes
US9096537B1 (en)	2014-12-31	2015-08-04	Mahesh Kandula	Compositions and methods for the treatment of mucositis
WO2016110865A1 (en)	2015-01-06	2016-07-14	Cellix Bio Private Limited	Compositions and methods for the treatment of inflammation and pain
CA2976314C (en)	2014-09-26	2021-02-23	Cellix Bio Private Limited	Compositions and methods for the treatment of epilepsy and neurological disorders
EP3201168B1 (en)	2014-09-29	2020-03-18	Cellix Bio Private Limited	Compounds and compositions for the treatment of multiple sclerosis
EP3212626B1 (en)	2014-10-27	2018-11-07	Cellix Bio Private Limited	Three component salts of fumaric acid monomethyl ester with piperazine or ethylene diamine for the treatment of multiple sclerosis
US9290486B1 (en)	2014-11-05	2016-03-22	Cellix Bio Private Limited	Compositions and methods for the treatment of epilepsy
US9321716B1 (en)	2014-11-05	2016-04-26	Cellix Bio Private Limited	Compositions and methods for the treatment of metabolic syndrome
US9175008B1 (en)	2014-11-05	2015-11-03	Cellix Bio Private Limited	Prodrugs of anti-platelet agents
US9284287B1 (en)	2014-11-05	2016-03-15	Cellix Bio Private Limited	Compositions and methods for the suppression of carbonic anhydrase activity
US9150557B1 (en)	2014-11-05	2015-10-06	Cellix Bio Private Limited	Compositions and methods for the treatment of hyperglycemia
US10208014B2 (en)	2014-11-05	2019-02-19	Cellix Bio Private Limited	Compositions and methods for the treatment of neurological disorders
US9173877B1 (en)	2014-11-05	2015-11-03	Cellix Bio Private Limited	Compositions and methods for the treatment of local pain
US9932294B2 (en)	2014-12-01	2018-04-03	Cellix Bio Private Limited	Compositions and methods for the treatment of multiple sclerosis
US9206111B1 (en)	2014-12-17	2015-12-08	Cellix Bio Private Limited	Compositions and methods for the treatment of neurological diseases
CN106632530A (zh) *	2016-12-08	2017-05-10	陕西大生制药科技有限公司	高纯度托吡酯的制备方法
CN108341844A (zh) *	2018-04-25	2018-07-31	广州小桔生物科技有限公司	一种高纯度托吡酯的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4513006A (en) *	1983-09-26	1985-04-23	Mcneil Lab., Inc.	Anticonvulsant sulfamate derivatives
US4582916A (en) *	1983-09-26	1986-04-15	Mcneilab, Inc.	Chlorosulfate and azidosulfate esters of tetrahydro-2H-pyran-2-yl-methanol
AU651244B2 (en) *	1991-09-19	1994-07-14	Mcneilab, Inc.	Process for the preparation of chlorosulfate and sulfamate derivatives of 2,3:4,5-bis-0-(1-methylethylidene)-beta-D- fructopyranose and (1-methylcyclohexyl)methanol

2004
- 2004-02-03 UA UAA200508358A patent/UA81657C2/ru unknown
- 2004-03-01 US US10/790,274 patent/US7157589B2/en not_active Expired - Lifetime
- 2004-03-02 RU RU2005127626/04A patent/RU2333216C2/ru active
- 2004-03-02 JP JP2006508970A patent/JP4725976B2/ja not_active Expired - Fee Related
- 2004-03-02 AU AU2004217974A patent/AU2004217974A1/en not_active Abandoned
- 2004-03-02 EP EP04716438A patent/EP1599490B8/en not_active Expired - Lifetime
- 2004-03-02 MX MXPA05009384A patent/MXPA05009384A/es active IP Right Grant
- 2004-03-02 DK DK04716438T patent/DK1599490T3/da active
- 2004-03-02 PT PT04716438T patent/PT1599490E/pt unknown
- 2004-03-02 CA CA002517964A patent/CA2517964A1/en not_active Abandoned
- 2004-03-02 SI SI200431098T patent/SI1599490T1/sl unknown
- 2004-03-02 DE DE602004019191T patent/DE602004019191D1/de not_active Expired - Lifetime
- 2004-03-02 AT AT04716438T patent/ATE421521T1/de not_active IP Right Cessation
- 2004-03-02 NZ NZ541811A patent/NZ541811A/en unknown
- 2004-03-02 WO PCT/US2004/006263 patent/WO2004078769A1/en active Application Filing
- 2004-03-02 KR KR1020057016420A patent/KR20050119111A/ko not_active Application Discontinuation
- 2004-03-02 ES ES04716438T patent/ES2254047T3/es not_active Expired - Lifetime
- 2004-03-02 BR BRPI0407967-1A patent/BRPI0407967A/pt not_active IP Right Cessation
- 2004-03-02 CN CNB2004800057108A patent/CN100376591C/zh not_active Expired - Fee Related
- 2004-03-03 TW TW093105458A patent/TW200504089A/zh unknown
- 2004-03-03 MY MYPI20040728A patent/MY139235A/en unknown
- 2004-03-04 AR ARP040100680A patent/AR043466A1/es not_active Application Discontinuation
- 2004-03-04 CL CL200400438A patent/CL2004000438A1/es unknown
2005
- 2005-08-31 HR HR20050756A patent/HRP20050756A2/xx not_active Application Discontinuation
- 2005-10-03 ZA ZA200507995A patent/ZA200507995B/en unknown
- 2005-10-03 NO NO20054538A patent/NO20054538L/no not_active Application Discontinuation
2006
- 2006-08-04 HK HK06108677A patent/HK1088336A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
HRP20050756A2 (en)	2006-07-31
DE602004019191D1 (de)	2009-03-12
EP1599490A1 (en)	2005-11-30
NO20054538L (no)	2005-10-03
NZ541811A (en)	2008-07-31
CL2004000438A1 (es)	2005-01-21
TW200504089A (en)	2005-02-01
JP2006519860A (ja)	2006-08-31
ES2254047T1 (es)	2006-06-16
AU2004217974A1 (en)	2004-09-16
ATE421521T1 (de)	2009-02-15
RU2005127626A (ru)	2006-01-27
KR20050119111A (ko)	2005-12-20
ZA200507995B (en)	2007-01-31
JP4725976B2 (ja)	2011-07-13
CN1756760A (zh)	2006-04-05
BRPI0407967A (pt)	2006-03-07
HK1088336A1 (en)	2006-11-03
MXPA05009384A (es)	2006-02-28
AR043466A1 (es)	2005-07-27
CN100376591C (zh)	2008-03-26
US7157589B2 (en)	2007-01-02
US20040215004A1 (en)	2004-10-28
EP1599490B8 (en)	2009-04-08
PT1599490E (pt)	2009-04-03
RU2333216C2 (ru)	2008-09-10
CA2517964A1 (en)	2004-09-16
EP1599490B1 (en)	2009-01-21
WO2004078769A1 (en)	2004-09-16
SI1599490T1 (sl)	2009-06-30
ES2254047T3 (es)	2009-05-14
UA81657C2 (ru)	2008-01-25
MY139235A (en)	2009-09-30

Publication	Publication Date	Title
DK1599490T3 (da)	2009-04-27	Fremgangsmode til fremstilling af antikonvulsive derivater af topiramat
DK2377931T3 (da)	2013-07-08	Varianter af glycosidhydrolase
DK1667986T3 (da)	2013-05-06	Acetonesolvat af dimethoxydocetaxel og fremgangsmåde til fremstilling heraf
DK1687066T3 (da)	2012-11-26	Fremgangsmåder til immunmodulering
DK1638468T3 (da)	2007-12-17	Fremgangsmåde til coating af hudpiercingmikrofremspring
DE602004032192D1 (de)	2011-05-26	Rahmenstruktur einer Turbomaschine
DK1606261T3 (da)	2010-01-18	Hidtil ukendt fremgangsmåde til fremstilling af roflumilast
DK2135957T3 (da)	2019-05-13	Fremgangsmåde til fremstilling af glucaner
DE602004002817D1 (de)	2006-11-30	Gleichzeitige Magnetimpuls-Rahmenbildung
DK1353923T3 (da)	2005-01-31	Forbedret fremgangsmåde til syntese af carbapenem
DE602004027322D1 (de)	2010-07-08	Übertragungssynchronisierung
FI20030771A (fi)	2004-11-22	Menetelmä toksisten syanobakteerien määrittämiseksi
DK1575941T3 (da)	2012-07-09	Fremgangsmåde til fremstilling af (S)-pantoprazol
DK1294659T3 (da)	2008-03-17	Fremgangsmåde til isolering af katamin
NO20035626D0 (no)	2003-12-17	Metode
DE502004000456D1 (de)	2006-06-01	Ventilsteuerung
FI20000325A0 (fi)	2000-02-15	Menetelmä rakenteen rasituksen määrittämiseksi
GB0514455D0 (en)	2005-08-17	Method of making structural members
FR2855730B1 (fr)	2007-03-30	Surmatelas de relaxation
DK1558624T3 (da)	2006-05-15	Kontinuert fremgangsmåde til fremstilling af fructopyranosesulfamatderivater
FR2851121B1 (fr)	2006-01-06	Dechaumeuse de precision
DK1229109T3 (da)	2004-02-02	Fremgangsmåde til fremstilling af glucose-1-phosphat
DE112004002270D2 (de)	2006-10-19	Pupillometrisches Verfahren
EP1694837A4 (en)	2008-07-23	Method
FI20030747A0 (fi)	2003-05-19	Toremifeenin kiteytysmenetelmä